Benzinga | Nov 5, 2020 04:29PM EST

Kezar Life Sciences Q3 EPS $(0.23) Up From $(0.48) YoY

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.23) per share. This is a 52.08 percent increase over losses of $(0.48) per share from the same period last year.